Hematology/Oncology Education and CME

Select a Specialty

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing Over the Past 3 Months
CMEABIM MOC

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing Over the Past 3 Months

There is no commercial support for this activity.

Expiration Date: 2/14/2019
Credit Type(s): CME / ABIM/CME | Credit: 0.25

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who has a brown pigmented lesion that has been changing…

go to activity »
EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care
CME

EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Expiration Date: 1/16/2019
Credit Type(s): CME | Credit: 0.5

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of all cancer-related deaths. In 2018, it is…

go to activity »
Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective
CME

Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 1/15/2019
Credit Type(s): CME | Credit: 0.5

The integration of immunotherapies into management strategies for the treatment of numerous hard-to-treat malignancies has provided significant improvements in clinical…

go to activity »
Applying Advances with Checkpoint Inhibitors in Thoracic Oncology
CME

Applying Advances with Checkpoint Inhibitors in Thoracic Oncology

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 1/21/2019
Credit Type(s): CME | Credit: 1

Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung cancer will occur in the United States in 2018…

go to activity »
Ace the Case: 61-Year-Old Male Who Presents to the ER with Worsening Back Pain
CMEABIM MOC

Ace the Case: 61-Year-Old Male Who Presents to the ER with Worsening Back Pain

There is no commercial support for this activity.

Expiration Date: 12/14/2018
Credit Type(s): CME / ABIM/CME | Credit: 0.25

This “Ace the Case” activity will review the diagnosis and management of patients with high-risk multiple myeloma utilizing a case-based approach….

go to activity »
But How Similar is it? What You Need to Know and What to Tell Your Patients About Biosimilars
CMECPE

But How Similar is it? What You Need to Know and What to Tell Your Patients About Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

Expiration Date: 12/19/2018
Credit Type(s): CPE / CME | Credit: 1

As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will require education about the appropriate incorporation…

go to activity »
Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers
CME

Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers

This educational activity is supported by an independent medical educational grant from Merck & Co., Inc.

Expiration Date: 2/5/2019
Credit Type(s): CME | Credit: 0.75

The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis of recent clinical studies have demonstrated that…

go to activity »
Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances
CME

Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals, Inc.

Expiration Date: 1/16/2019
Credit Type(s): CME | Credit: 1

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients diagnosed with HCC is challenging, as tumor stage and…

go to activity »
Ace the Case: A 70-Year-Old Woman with Cough and a Lung Mass
CMEABIM MOC

Ace the Case: A 70-Year-Old Woman with Cough and a Lung Mass

There is no commercial support for this activity.

Expiration Date: 1/14/2019
Credit Type(s): CME / ABIM/CME | Credit: 0.25

This “Ace the Case” activity will discuss the diagnosis and management of a 70-year-old woman with cough and a lung mass on CT scan….

go to activity »
Addressing Common Patient Concerns Regarding Biosimilars
CMECPE

Addressing Common Patient Concerns Regarding Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

Expiration Date: 12/19/2018
Credit Type(s): CME / CPE | Credit: 0.25

As more biosimilars are approved for use in the United States, greater emphasis is needed on educating patients about their treatment options, the use of biosimilars…

go to activity »
Overcoming Barriers and Best Practices for Use of Biosimilars: Conversations Between Physicians and Pharmacists
CMECPE

Overcoming Barriers and Best Practices for Use of Biosimilars: Conversations Between Physicians and Pharmacists

This activity is supported by an educational grant from Pfizer, Inc.

Expiration Date: 12/19/2018
Credit Type(s): CME / CPE | Credit: 0.5

As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will require education about the appropriate incorporation…

go to activity »
Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks
CMEABIM MOC

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

Expiration Date: 11/14/2018
Credit Type(s): CME / ABIM/CME | Credit: 0.25

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent, painless hematuria for the past 4 weeks. Accurately…

go to activity »